Jayant Nath, MD
Cardiovascular Disease · Kansas City, KSNPI 1194778613
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,250 of the $17,905 with a category attached, or 90.8%. Lantheus Medical Imaging, Inc. accounts for 97.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $11,914 and has fallen 98.8% since, to $141 in 2025. Among cardiovascular disease clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $559.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$17K
- Boston Scientific$262
- Abbott$114
- AstraZeneca$35
- Amgen$19
- Sanofi-aventis U.S. LLC$12
What the payments were for
- Speaking & faculty fees$16,25091%
- Travel & lodging$9455%
- Food & beverage$6934%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 25 | $17,464 |
| Boston Scientific | 2 | $262 |
| Abbott | 1 | $114 |
| AstraZeneca | 2 | $35 |
| Amgen | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Definity$17,030
- WATCHMAN FLX$141
- Watchman$121
- ViewFlex Xtra ICE Catheter$114
How this compares
$17,905 in reported general payments places this provider in the 90th percentile of 175 cardiovascular disease providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 62 | $74,125 |
| EntrestoSacubitril/Valsartan | 26 | $27,747 |
| Metoprolol Succinate | 102 | $1,103 |
| Atorvastatin Calcium | 122 | $1,057 |
| Ezetimibe | 36 | $840 |
| Carvedilol | 97 | $831 |
| Nifedipine ErNifedipine | 19 | $704 |
| Rosuvastatin Calcium | 79 | $643 |
| Losartan Potassium | 50 | $409 |
| Amlodipine Besylate | 48 | $386 |
| Potassium Chloride | 14 | $346 |
| Bumetanide | 12 | $287 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 23 | $256 |
| ClopidogrelClopidogrel Bisulfate | 26 | $240 |
| Lisinopril | 29 | $177 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Kansas City
- Timothy BeaverKansas City$22K
- Donald McSweynKansas City$12K
- Jean-Alfred ThomasKansas City$11K
- Seyedhamed HosseinidehkordiKansas City$8K
- Mohammad AlarfajKansas City$7K
- Matthew KellingKansas City$6K
- Justin UgwuKansas City$5K
- Jonathan FreemanKansas City$4K
- Abdulrahman MoradKansas City$4K
- Siva TaduruKansas City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.